Optimization of Formulation and Treatment Regimen of BIIB091, a Non-Covalent Bruton's Tyrosine Kinase Inhibitor

Hui-Hsin Tsai, Gab-jin Park, Mark Milad,Vanessa Zann, Phil Evans, Wu Lin, Yi-Da Chiu,Katherine Riester,Eris Bame, Sue Sweet-Smith,Jorge A. Torres, Michael Soliman,Jerome Hanna, Bing Zhu

MULTIPLE SCLEROSIS JOURNAL（2023）

Cited 0|Views19

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined